8-86671107-GA-GAA
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The NM_019098.5(CNGB3):c.339-10dupT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00182 in 1,611,972 control chromosomes in the GnomAD database, including 39 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0096 ( 22 hom., cov: 32)
Exomes 𝑓: 0.0010 ( 17 hom. )
Consequence
CNGB3
NM_019098.5 intron
NM_019098.5 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.108
Genes affected
CNGB3 (HGNC:2153): (cyclic nucleotide gated channel subunit beta 3) This gene encodes the beta subunit of a cyclic nucleotide-gated ion channel. The encoded beta subunit appears to play a role in modulation of channel function in cone photoreceptors. This heterotetrameric channel is necessary for sensory transduction, and mutations in this gene have been associated with achromatopsia 3, progressive cone dystrophy, and juvenile macular degeneration, also known as Stargardt Disease. [provided by RefSeq, Feb 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP6
Variant 8-86671107-G-GA is Benign according to our data. Variant chr8-86671107-G-GA is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 261087.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=2, Benign=1}.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00958 (1451/151460) while in subpopulation AFR AF= 0.033 (1364/41310). AF 95% confidence interval is 0.0316. There are 22 homozygotes in gnomad4. There are 701 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 22 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CNGB3 | NM_019098.5 | c.339-10dupT | intron_variant | ENST00000320005.6 | NP_061971.3 | |||
CNGB3 | XM_011517138.3 | c.-76-10dupT | intron_variant | XP_011515440.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CNGB3 | ENST00000320005.6 | c.339-10dupT | intron_variant | 1 | NM_019098.5 | ENSP00000316605.5 | ||||
CNGB3 | ENST00000680314.1 | n.100-10dupT | intron_variant | |||||||
CNGB3 | ENST00000681746.1 | n.339-10dupT | intron_variant | ENSP00000505959.1 |
Frequencies
GnomAD3 genomes AF: 0.00959 AC: 1452AN: 151344Hom.: 22 Cov.: 32
GnomAD3 genomes
AF:
AC:
1452
AN:
151344
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00246 AC: 615AN: 249788Hom.: 5 AF XY: 0.00187 AC XY: 253AN XY: 135132
GnomAD3 exomes
AF:
AC:
615
AN:
249788
Hom.:
AF XY:
AC XY:
253
AN XY:
135132
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00102 AC: 1488AN: 1460512Hom.: 17 Cov.: 32 AF XY: 0.000888 AC XY: 645AN XY: 726576
GnomAD4 exome
AF:
AC:
1488
AN:
1460512
Hom.:
Cov.:
32
AF XY:
AC XY:
645
AN XY:
726576
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00958 AC: 1451AN: 151460Hom.: 22 Cov.: 32 AF XY: 0.00947 AC XY: 701AN XY: 73998
GnomAD4 genome
AF:
AC:
1451
AN:
151460
Hom.:
Cov.:
32
AF XY:
AC XY:
701
AN XY:
73998
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:3
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Achromatopsia Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Stargardt Disease, Recessive Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at